HOME >> BIOLOGY >> NEWS
Biotech cotton provides same yield with fewer pesticides

Arizona farmers receive the same yield/acre, use fewer chemical insecticides and maintain insect biodiversity when they plant the biotech cotton known as Bt cotton, according to new research.

The finding comes from the first large-scale study that simultaneously examined how growing Bt cotton affects yield, pesticide use and biodiversity.

It's good news for the environment.

"What we see is that it's positive here in Arizona -- no doubt about it," said Yves Carrire, an associate professor of entomology at The University of Arizona in Tucson. "We've reduced pesticide use in Arizona. We've wanted to do that for 25 years."

Bt cotton has been genetically altered to produce Bt toxin, a naturally occurring insecticide that kills pink bollworm, a major pest of cotton. Bt cotton has been planted in Arizona since 1996. Now more than half of the state's 256,000 acres of cotton fields are planted with the biotech plants.

Some have suggested that, in addition to killing the target pests, insecticide-containing crops like Bt cotton would also kill beneficial and non-target arthropods.

The new study found that Bt cotton, also known as transgenic cotton, does not affect the biodiversity of insects in cotton fields.

Carrire said, "There were lots of factors that affected biodiversity in this study. Transgenics were not one of them."

He and his colleagues based their findings on a two-year study of 81 commercial cotton fields in a region of Arizona that spans about 2,500 square miles (6,600 square kilometers). Much of the field and lab work was done by Manda G. Cattaneo as part of her master's research at UA. Cattaneo is now an extension entomologist at Texas A&M University in College Station.

The multidisciplinary team will publish their research in an upcoming issue of the Proceedings of the National Academy of Sciences. A complete list of authors is at the end of this release. The Environmental Prote
'"/>

Contact: Mari N. Jensen
mnjensen@email.arizona.edu
520-626-9635
University of Arizona
1-May-2006


Page: 1 2 3

Related biology news :

1. Biotech breakthrough could end biodiesels glycerin glut
2. How the Biotech Revolution Is Changing the Way We Fight Disease
3. Rutgers: GM/GMO/Biotech crop containment strategy
4. Ronald Cape to receive 2007 Biotechnology Heritage Award
5. Oncolytics Biotech Inc., research collaborators demonstrate reovirus/gemcitabine
6. Oncolytics Biotech Inc. proceeds to initiate US Phase II sarcoma clinical trial
7. Biotechnology Study Center honors Joan V. Ruderman, Salvador Moncada and Charles N. Serhan
8. European Federation of Biotechnology and Elsevier announce launch of biotechnology journal
9. Advances in Optics for Biotechnology, Medicine and Surgery
10. Biolex reports potential for more potent, efficacious antibodies in Nature Biotechnology
11. Developing uses for sugar-cane bagasse: Biotechnology applied to the paper industry

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Biotech cotton provides same yield with fewer pesticides

(Date:7/23/2014)... Ind. Spinach gave Popeye super strength, but it ... a group of scientists: the ability to convert sunlight ... physicists are part of an international group using spinach ... by which plants convert the sun,s energy into carbohydrates ... study are part of the most efficient system ever ...
(Date:7/23/2014)... , , , ... , , , , ... lifespan. The idea, they argue, would be to target the... , , ... , , , , ... , , , , , , , Medicine focuses almost entirely on ...
(Date:7/23/2014)... its grip is affecting more than the color of people,s ... a heat-loving amoeba commonly found in warm freshwater bodies, such ... made warmer than usual this year. , A 9-year-old Kansas ... after swimming in several area lakes. The amoeba enters the ... the brain. Nose plugs can lower the odds of this ...
Breaking Biology News(10 mins):Spinach could lead to alternative energy more powerful than Popeye 2Strategy proposed for preventing diseases of aging 2Strategy proposed for preventing diseases of aging 3Strategy proposed for preventing diseases of aging 4Strategy proposed for preventing diseases of aging 5Diseases of another kind 2
(Date:7/23/2014)... , July 23, 2014  Having the right people ... vital to accelerating business growth and achieving clinical and ... Association (AHA) Leadership Summit, July 20-22, 2014, in ... of hospital executives and healthcare experts discussing how partnerships ... Carrocino , President & Chief Executive Officer of Cape ...
(Date:7/23/2014)... StemGenex® , the leading resource for ... at improving the lives of patients dealing with degenerative ... disease. StemGenex believes that a commitment to the ... when providing care to patients with degenerative diseases. ... accessible to the millions of individuals currently living with ...
(Date:7/23/2014)... Iowa (PRWEB) July 23, 2014 DuPont ... the business as vice president of Agricultural Biotechnology (ABT), ... Biotechnology where he served most recently as president, chief ... biotechnology and business leadership in the seed and crop ... said Paul E. Schickler , president of DuPont ...
(Date:7/23/2014)... -- regulated information -- UCB today announced an important ... positive topline results from the latest Phase 3 ... to evaluate the efficacy and safety of ... compared to placebo, as adjunctive treatment in adult ... controlled despite treatment with one or two concomitant ...
Breaking Biology Technology:MSC and Cape Regional Medical Center Partner to Improve Cost, Quality and Outcomes 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 3DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 2DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7
Cached News: